- Nuria Ajenjo
- Daniel Alba
- Inmaculada Almenara
- María Jesús Artiga
- Francisco De Luna
CNIO Biobank − authorised by the Health Authorities of the Comunidad Autónoma de Madrid (CAM) and registered in the National Registry of Biobanks with reference B.000848 − is a ‘biobank for biomedical research purposes’, as defined by the Spanish Law 14/2007 and the Royal Decree RD 1716/2011. It is therefore defined as a public, non-profit organisation that hosts several collections of human biological samples for biomedical research, specifically in cancer and related diseases. The main objective of the CNIO Biobank is to facilitate access to human samples for researchers, ensuring that both the acquisition and use of human samples complies with all the legal and ethical principles that protect donors’ rights.
In addition to this biobanking activity, a number of services have been implemented, both for sample processing and for supporting different aspects of the management of human samples for biomedical research, in order to facilitate the use of human samples for CNIO researchers.
CNIO Biobank is a founder member of the Spanish Biobank Network, a project funded by the Instituto de Salud Carlos III, ISCIII, currently through the Acción Estratégica en Salud – AES 2017 supportive platforms for research programmes. CNIO Biobank leads and/or participates in many different projects such as: centralised request management system (design and development); ethical, legal and social issues (ELSI); harmonisation; biospecimen science; and marketing plans.
Therefore, CNIO Biobank is a cross-service platform for CNIO researchers, as well as the general scientific community, and is geared towards the promotion of biomedical research in cancer and related diseases.
- (2020). ACTN3 R577X Polymorphism Related to Sarcopenia and Physical Fitness in Active Older Women. Climacteric 30, 1-6. CNIO Publication.
- (2019). A Review of International Biobanks and Networks: Success Factors and Key Benchmarks-A 10-Year Retrospective Review.. Biopreservation & Biobanking 17, 512-519. CNIO Publication.
- (2019). In Search of an Evidence-Based Strategy for Quality Assessment of Human Tissue Samples: Report of the Tissue Biospecimen Research Working Group of the Spanish Biobank Network. J Transl Med 17, 370. CNIO Publication. Open Access
- (2018). In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer. Nat Commun 9, 3501. CNIO Publication. Open Access
- (2017). Quality Matters: 2016 Annual Conference of the National Infrastructures for Biobanking.. Biopreservation & Biobanking 15, 270-276. CNIO Publication.
- (2016). Analysis of Paired Primary-Metastatic Hormone-Receptor Positive Breast Tumors (HRPBC) Uncovers Potential Novel Drivers of Hormonal Resistance.. PLoS ONE 11, e0155840. CNIO Publication.
- (2016). Angioimmunoblastic T-cell lymphoma with a clonal plasma cell proliferation that underwent immunoglobulin isotype switch in the skin, coinciding with cutaneous disease progression.. J Cutan Pathol 43, 1203-1210. CNIO Publication.
- (2016). Annual Conference of the National Infrastructures for Biobanking. Biopreservation & Biobanking (in press). CNIO Publication.
- (2016). Deep sequencing reveals microRNAs predictive of antiangiogenic drug response.. JCI Insight 7, e86051. CNIO Publication.
CNIO Biobank (authorised by the Comunidad Autónoma de Madrid Health Department and registered in the National Registry of Biobanks with reference B.000848) is a ‘biobank for biomedical research purposes’, as defined by the Spanish Law 14/2007 and the Royal Decree RD 1716/2011. It´s therefore defined as a public, non-profit organization that hosts several human sample collections for biomedical research following quality and order criteria.